Viral Hepatitis Updates from the HHS Office of HIV/AIDS and Infectious Disease Policy
It’s hard to believe that it has been just over a year since the National Viral Hepatitis Action Plan 2017-2020 (Action Plan) was released. The updated Action Plan represents a new phase in the battle against viral hepatitis and is the nation’s roadmap for addressing viral hepatitis in the United States. It reflects recent trends in viral hepatitis infections and deaths, as well as new and improved strategies for prevention, care, and treatment.
Download the Action Plan Overview PDF
To better help our partners understand the goals of the Action Plan; use it as a tool to help address challenges and identify opportunities; and continue to play critical roles in the national response to viral hepatitis, we have developed a 2-page summary version of the Action Plan. We hope you will print out the 2-pager and share it with your networks, coalitions, and colleagues. Download the Action Plan Overview PDF by clicking here.
As our nation’s battle plan for eliminating viral hepatitis in the United States, the Action Plan outlines strategies to achieve four major goals and includes indicators to help track progress between now and 2020. Over the last year, many of our partners have developed programs, policy statements, and other activities that support the goals of the Action Plan. Some of these are highlighted below:
- Free Consultation Service: Hepatitis C Patient Management Support for Providers
- Hidden Casualties: Consequences of Opioid Epidemic on the Spread of Infectious Diseases
- VA Shares Successful New Strategies for Curing Hepatitis C Infection
- Policy Statement Released by the American Academy of Pediatrics Calls for the Elimination of Perinatal Hepatitis B
Over the coming weeks, you will be hearing about more opportunities to get involved including webinars, events, and more. We hope you will continue to join us in the fight as we move towards realizing the vision of our national Action Plan.
Richard Wolitski, PhD, and Corinna Dan, RN, MPH
Office of HIV/AIDS and Infectious Disease Policy
U.S. Department of Health and Human Services
What’s New in the Blog
- Increase in Maternal Hepatitis C Mirrors the Rise in Injection Drug Use. January 12, 2018. Perinatal transmission is the leading cause of childhood HCV infection. According to CDC, maternal HCV infections nearly doubled from 2009 to 2014, and the number of infants born to women who are infected with HCV also increased. Read more by clicking here.
Hepatitis in the News
- County Supervisors Consider Ending Hepatitis A State Of Emergency – County health officials earlier this month said that it may soon be time to end the declaration amid a declining number of cases and no additional deaths reported between the end of October and Jan. 2, which they said is a sign that the vaccination, education and sanitation efforts across the region have worked. January 23, 2018.
- States Face Costly Conundrum: How To Treat Inmates With Hepatitis C – Civil liberties groups in Missouri and at least seven other states are now suing to get more inmates treated with new-generation hepatitis C drugs that are highly effective but also costly. January 23, 2018.
- Simplifying Viral Hepatitis Testing Will Slow the Spread of Disease – Viral hepatitis B (HBV) and C (HCV) continue to spread because most people who are infected are unaware of their status. However, as technology evolves, more clinicians will be able to test and treat people in whom chronic hepatitis had formerly gone unchecked. January 19, 2017.